1976

• Villaverde CA, Badimon L, Bastida E, G-Valdecasas F
  Interacción uroquinasa-heparina.
  Archivos de Farmacologia y Toxicologia II: 3, 295-297, 1976.
  
  
• Villaverde CA, Iriarte JA, Masanet L, Borruel MT, Badimon L, G-Valdecasas F
  Modelo experimental en perros para el estudio de trombólisis
  Archivos de Farmacologia y Toxicologia II: 3, 294-295, 1976.
  
  
• Villaverde CA, Bastida E, Badimon L, G-Valdecasas F
  Propuesta para la estandarización de un método de control polivalente de la actividad fibrinolítica
  Archivos de Farmacologia y Toxicologia II: 293-294, 1976.
  

1977

• Villaverde CA, Pla-Delfina JM, Escolar G, Badimon L, G-Valdecasas F.
  Aportación al estudio cinético de la uroquinasa y su posible aplicación al establecimiento de regímenes de dosificación
  Archivos de Farmacologia y Toxicologia III: 75-77, 1977
  
• Villaverde CA, G-Valdecasas F, Escolar G, Badimon L
  Perfiles fibrinolíticos inducidos por la urokinasa (UK) in vivo e in vitro
  En: Avances en Farmacologia.
  Ed. F. G-Valdecasas, E. Rodriguez Farré
  Ed. Acacia. Barcelona, pp 367-381, 1977
  
  
• Villaverde CA, Badimon L, G-Valdecasas F
  Thrombosis and fibrinolytic system in the rat experimental atherosclerosis
  En: Atherosclerosis, IV.
  Ed. G. Schetler, Y. Goto, G. Hata and G. Klose
  New York, pp 622, 1977.
  
  
• Villaverde CA, Badimon L, Bastida E, G-Valdecasas F
  Proposition of standardization of one method for polyvalent control of fibrinolytic activity
  En: Proc. of the Tenth International Congress of Angiology
  Ed. K. Seki, Y. Mishima
  Tokyo, pp 212, 1977.
  
  
• Villaverde CA, Escolar G, Badimon L, G-Valdecasas F
  Etiopathogenic aspects of atherosclerosis in rat
  En: Proc. of the Tenth International Congress of Angiology
  Ed. K. Seki, Y. Mishima
  Tokyo, pp 285-286, 1977
  

1978

• Badimon L, Villaverde CA, Bastida E, Badimon JJ, G-Valdecasas F
  Aportación al estudio de los inhibidores de la fibrinólisis
  Archivos de Farmacologia y Toxicologia IV: 98-99, 1978.
  

1979

• Villaverde CA, Badimon L, Badimon JJ
  Heparina y Sistema Fibrinolítico.
  Annals de Medicina LXV: 8, 1204-1214, 1979.
  
  
• Villaverde CA, Badimon L, Badimon JJ, G-Valdecasas F
  Interacción heparia y uroquinasa en el sistema fibrinolítico
  Archivos de Farmacologia y ToxicologiaV: 3, 268-269, 1979.
  
  
• Badimon L, Villaverde CA, Vidal M, G-Valdecasas F
  Heparina de bajo peso molecular y uroquinasa de alto y bajo peso molecular en la fibrinólisis in vivo
  Archivos de Farmacologia y Toxicologia V: 3, 262-264, 1979.
  
  
• Badimon JJ, Villaverde CA, Badimon L, G-Valdecasas F
  Hiperlipoproteinemia e inhibidores de la fibrinólisis
  Archivos de Farmacologia y Toxicologia V: 3, 265-267, 1979
  
• Villaverde CA, Bastida E, Vidal M, Badimon L, G-Valdecasas F
  Urokinase influence on rat platelet aggregation
  En: Progress in Chemical Fibrinolysis and Thrombolysis Vol. IV.
  Ed. J. F. Davidson, V. Cepelák, M.M. Samama, P.C. Desnoyers.
  Churchill Livingstone, London, pp 216-219, 1979
  

1980

• Badimon L, Villaverde CA, Vidal M, Badimon JJ, G-Valdecasas F
  Estudio comparativo del sistema fibrinolítico en diferentes especies animales.
  Archivos de Farmacologia y Toxicologia VI: 17-26, 1980
  
• Badimon L, Villaverde C, Bastida E, G-Valdecasas F.
  Inhibitors influence on the fibrinolytic response to urokinase treatment.
  En: Proc. V. International Congress on Thromboembolism.
  Ed. Cocheri
  Bolonia, pp 349-350, 1980

1981

• Badimon JJ, Padro T, Badimon L, Bruseghini L, Villaverde CA
  Aspectos farmacológicos del ácido tienílico
  Archivos de Farmacologia y Toxicologia VII: 1- 6, 1981.
  
  
• Villaverde CA, Badimon L , Badimon JJ, Vidal M, G-Valdecasas F
  Heparina e inhibidores de la fibrinólisis
  Archivos de Farmacologia y Toxicologia VII: 97-101, 1981.
  
  
• Badimon L, Villaverde CA, Badimon JJ, Vidal M, G-Valdecasas F
  Influencia de la heparina sódica en la fibrinolisis activada en la rata in vivo
  Archivos de Farmacologia y Toxicologia VII: 105-108, 1981.
  
  
• Badimon L, Villaverde CA, Vidal M, Badimon JJ, Miret M
  Estudio de los inhibidores del sistema fibrinolítico en diferentes especies animales e influencia del tiempo y temperatura en su conservación.
  Archivos de Farmacologia y Toxicologia VII: 101-104, 1981.
  
  
• Badimon JJ, Villaverde CA, Badimon L, Padro T, G-Valdecasas F.
  Modificación de la fracción colesterol-HDL en la arteriosclerosis experimental.
  Archivos de Farmacologia y Toxicologia VII: 109-112, 1981.
  
  
• Badimon L, Badimon JJ, Cánovas M, G-Valdecasas F, Villaverde CA.
  Alteraciones hemostáticas inducidas por dietas aterogénicas
  En: "40 Años de Farmacologia en España"
  Ed. Facultad Medicina. Barcelona, pp 266-269, 1981
  

1982

• Badimon L, Fuster V, Dewanjee MK Romero JC
  A sensitive new method of "ex vivo" platelet deposition
  Thrombosis Research 28, 237-250, 1982
  

1983

• Badimon L, Fuster V, Chesebro JH, Dewanjee MK
  New "ex vivo" radioisotopic method of quantitation of platelet deposition : Studies in four animal species.
  Thrombosis and Haemostasis 50, 3, 639-644, 1983.
  
• Fuster V, Badimon L
  Platelets and atherosclerosis.
  In: Educational Manual of the 7th Meeting of the I. S. Haematology
  (European and African Division)
  Ed. C. Rozman, A. Raichs,
  Barcelona pp 81-88, 1983.
  
• Fuster V, Chesebro JH, Badimon L, Offord KP, Wahner HW
  Platelet survival.
  In: Measurements of Platelet Function
  Ed. L.A. Harker and T.S. Zimmerman
  Churchill Livingston (vol. 8), pp 189-215. 1983.
  
• Fuster V, Badimon L, Rosemark J. Bowie EJW
  Platelet-arterial wall interaction: Quantitative and qualitative study following selective carotid endothelial injury in normal and von Willebrand pigs.
  Clinical Research 31:2,459A. 1983
  

1984

• Nordoy A, Killie JE, Badimon L, Fass DN, Mao SJT, Maciejko JJ
  The effect of lipoproteins on the synthesis of prostacyclin, von Willebrand factor and apoliproteins A-I and A-II in cultured human endothelial cells.
  Atherosclerosis 50, 307-323, 1984.
  
• Chesebro JH, Ezekovitz MRD, Badimon L, Fuster V
  Intracardiac thrombosis: occurrence, detection and treatment
  Journal Cardiol. Medicine 9: 409-414, 1984.
  
• Steele PM, Fuster V, Chesebro JH, Badimon L, Gorlin R
  The role of platelet-inhibiting drugs in cardiovascular therapy.
  In: Recent Advances in Cardiology.
  Ed. D. J. Rowlands
  Churchill-Livingstone, (vol. 9) pp 169-192, 1984.
  

1985

• Fuster V, Badimon L, Rosemark JA, Badimon JJ, Lie J, Bowie EJW
  Spontaneous and diet-induced coronary atherosclerosis in normal swine and swine with von Willebrand disease
  Arteriosclerosis 5, 67-73, 1985.
  
  
• Steele PM, Chesebro JH, Stanson AW, Holmes DR Jr., Dewanjee MK, Badimon L, Fuster V
  Balloon angioplasty: Natural history of the pathophysiological response to injury in a pig model
  Circulation Research 57, 105-112, 1985.
  
  
• Badimon L, Steele P, Badimon JJ, Bowie EJW, Fuster V Aortic atherosclerosis in pigs with heterozygous von Willebrand disease. Comparison with homozygous von Willebrand and normal pigs.
  Arteriosclerosis 5, 366-370, 1985.
  
  
• Chesebro JH, Ezekowitz M, Badimon L, Fuster V
  Intracardiac thrombi and systemic thromboembolism: detection, incidence and treatment
  Annual Review of Medicine 36, 579-605, 1985.
  
• Fuster V, Badimon L, Badimon JJ
  Patogenia de la aterosclerosis.
  En: Cardiopatía Isquémica
  Eds. P. Zarco and J. Saez de la Calzada
  Editorial Doyma, Madrid (Capítulo 1) pp 1-22 , 1985.
  
  
• Fuster V, Badimon L, Chesebro JH
  Coronary artery bypass grafting - A model for the understanding of the progression of atherosclerotic disease and the role of platelet-inhibitor drugs.
  In: Atheroma and Thrombosis.
  Ed. V. Kakkar
  Pitman, London July pp 59-72, 1985.
  
  
• Fuster V, Pumphrey CW, Chesebro JH, Badimon L, Steele PM, DewanjeeMK
  Antithrombotic action of calcium antagonists in the dog model.
  In: Proceeding IX European Congress Cardiology
  Ed. PR Lichtlen
  Schattauer, Stuttgart, pp 149-159, 1985.
  
  
• Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V
  High density lipoproteins and the arachidonic acid metabolic pathway in the vessel wall.
  Clinical Research 33:2,167, 1985
  
  
• Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V
  Vessel wall atherosclerotic disease and prostanoid metabolism.
  Clinical Research 33:2, 167A, 1985
  
  
• Vallabhajosula S, Ginsberg HN, Badimon JJ, Le N-A, Badimon L, Galvez A, Goldsmith J, Fuster V
  99mTc-Low density lipoprotein: A new agent for studying lipoprotein metabolism and imaging atherosclerotic lesions in vivo.
  Clinical Research, 33:2,234A, 1985
  
  
• Vallabhajosula S, Machac J, Badimon L, Goldsmith SJ, Fuster V
  Measurement of platelet life span: "Indium-platelet method vs platelet thromboxane radioimmunoassay method.
  Clinical Research, 33:2,355A, 1985
  
  
• Vallabhajosula S, Machac J, Badimon L, Lipszyc H, Goldsmith SJ, Fuster V
  Evaluation of platelet thromboxane radioimmoassay method to measure platelet life-span: Comparison with 111Indium-platelet method.
  32nd Annual Meeting of Society of Nuclear Medicine. Houston, Texas, June 2-5, No. 195, 1985.
  
  
• Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V
  Modification of vessel wall prostacyclin production by high density lipoproteins.
  Thrombosis and Haemostasia ;54,51, 1985
  
  
• Badimon JJ, Vallabhajosula S, Ginsberg H, Badimon L, Galvez A, Le Na, Goldsmith SJ, Fuster V
  New non-invasive technique to detect lipid deposition in experimental atherosclerosis disease.
  Thrombosis and Haemostasia, 54,85, 1985
  
  
• Badimon JJ, Galvez A, Badimon L, Mao S, Fuster V
  High density lipoproteins and experimental rabbit arterial disease.
  Thrombosis and Haemostasia, 54,86, 1985
  
  
• Badimon L, Badimon JJ, Galvez A, Fuster V
  Aortic wall hyperplasia and prostacyclin production.
  Thrombosis and Haemostasia, 54,85, 1985
  
  
• Badimon L, Badimon JJ, Galvez A, Fuster V
  Stimulatory effect of high density lipoproteins on vessel wall prostaglandin synthesis.
  Circulation, 72:4-11,#1120, 1985
  
  
• Badimon JJ, Badimon L, Galvez A, Chesebro JH, Fuster V
  Effect of increased high density lipoprotein levels on platelet function.
  Circulation 72:4-11,#1686, 1985
  

1986

• Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V
  Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model
  Arteriosclerosis 6, 312-320, 1986.
  
  
• Vallabhajosula S,Machac J,Goldsmith SJ, Lipszyc H, Badimon L, Rand J, FusterV
  Indium-111 platelet kinetics in normal human subjects : Tropolone versus oxine methods
  Journal of Nuclear Medicine 27, 1669-1674, 1986.
  
  
• Galvez A, Badimon L, Badimon JJ, Fuster V
  Electrical aggregometry in whole blood from human, pig and rabbit.
  Thrombosis and Haemostasis 56, 128-132, 1986.
  
  
• Lam JYT, Chesebro JH, Steele PM, Dewanjee MK, Badimon L, Fuster V
  Deep arterial injury during experimental angioplasty: Relation to a positive Indium-111 labeled platelet scintigram, quantitative platelet deposition and mural thrombosis
  Journal of the American College of Cardiology 8, 1380-1386, 1986.
  
• Badimon L, Badimon JJ, Fuster V
  Platelet-vessel wall interaction and von Willebrand disease. Evidence for the role of platelets in atherosclerosis.
  Biologia & Clínica Haematológica 8: 37-71, 1986.
  
• Fuster V, Badimon L, Badimon JJ
  Patogenia de la aterosclerosis.
  En: Cardiologia Básica (Medicine)
  Ed. P. Zarco
  Idepsa, Madrid (Capítulo 15) pp 298-315, 1986.
  
  
• Fuster V, Badimon L, Badimon JJ, Turitto V, Lie JT, Bowie EJW
  Experimental approach to vascular disease in swine with von Willebrand's disease.
  In: Swine in Biomedical Research
  Ed. M. E. Tumbleson
  Plenum Publishing Corp. , pp 1527-1542, 1986
  
• Badimon L, Badimon JJ, Galvez A, Chesebro JH, Gorlin R, Fuster V
  Effect of HDL on atherosclerotic vessel wall prostaglandin synthesis in vivo.
  Clinical Research 34:2,626A, May 1986
  
  
• Galvez A, Camuñas J, Badimon L, Vallabhajosula S, Badimon JJ, Chesebro JH, Fuster V
  Platelet deposition kinetics on a synthetic vascular graft.
  Clinical Research ;34:2.626A, May 1986
  

1987

• Lam JYT, Chesebro JH, Steele PM, Badimon L, Fuster V
  Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo
  Circulation 75, 243-248, 1987.
  
  
• Rand JH, Badimon L, Gordon RE, Uson RR, Fuster V
  Distribution of von Willebrand Factor in porcine intima varies with blood vessel type and location
  Arteriosclerosis 7, 287-291, 1987.
  
  
• Badimon L, Badimon JJ, Turitto VT, Fuster V
  Thrombosis: studies under flow conditions
  Annals of the New York Academy of Sciences 516, 527-540, 1987.
  
  
• Badimon L, Turitto VT, Rosemark JA, Badimon JJ, Fuster V
  Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: Deposition of Indium-111 labeled platelets on collagen, subendothelium and expanded polytetrafluoroethylene.
  Journal of Laboratory and Clinical Medicine 110, 706-718, 1987.
  
  
• Adams PC, Lam JYT, Badimon L, Chesebro JH, Fuster V
  Interactions of platelets and vessel wall in the development of restenosis after coronary angioplasty
  Annals of the New York Academy of Sciences 516, 605-620, 1987.
  
  
• Turitto VT, Weiss HJ, Baumgartner HR, Badimon L, Fuster V
  Cells and aggregates at surfaces.
  Annals of the New York Academy of Sciences 516, 453-467, 1987.
  
  
• Badimon L, Badimon JJ, Rand J, Turitto VT, Fuster V
  Platelet deposition on von Willebrand Factor deficient vessels extracorporeal perfusion studies in swine with von Willebrand’s disease using native and heparinized blood.
  Journal of Laboratory and Clinical Medicine 110, 634-647, 1987.
  
  
• Adams PC, Fuster V, Badimon L, Badimon JJ, Chesebro JH
  Platelet-vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: Preventive strategies
  American Journal of Cardiology 60, 9G-16G, 1987.
  
  
• Chesebro JH, Lam JYT, Badimon L, Fuster V
  Restenosis after arterial angioplasty : A hemorrheologic response to injury
  American Journal of Cardiology 60, 10B-16B, 1987.
  
  
• Badimon L
  Summary : Methods of assessing thrombosis
  Annals of the New York Academy of Sciences 516, 651-652, 1987.
  
  
• Monsen CH, Adams PC, Badimon L, Chesebro JH, Fuster V
  Platelet-vessel wall interactions in the development of restenosis after coronary angioplasty.
  Z. Kardiologie 76, 23-28, 1987.
  
• Badimon L, Badimon JJ, Fuster V
  Pared arterial y ateriosclerosis.
  Revista Española de Geriatria y Gerontologia 22: 39-49, 1987.
  
  
• Badimon JJ, Badimon L, Galvez A, Fuster V
  HDL arteriosclerosis y prostaciclina
  Sangre 24: 80-83,1987.
  
  
• Badimon L, Badimon JJ, Turitto VT, Fuster V
  Role of von Willebrand Factor in platelet interaction expanded with an PTFE surface.
  American Society of Artificial Internal Organs 10, 621-625, 1987.
  
  
• Adams PC, Fuster V, Badimon JJ, Badimon L, Chesebro JH
  Role of platelets in atherogenesis. Relevance to coronary arterial restenosis after angioplasty.
  In: Cardiovascular Clinics 18 (1) - Thrombosis and Platelets in Myocardial Ischemia
  Ed. Brest AN and Metha JL
  F. A. Davis Co., Philadelphia, pp 49-71,1987.
  
  
• Badimon JJ, Badimon L, Galvez A, Fuster V
  Effect of high density lipoproteins on experimental atheroesclerosis.
  In: Cardiovascular Disease: Molecular and Cellular Mechanisms, Prevention, and Treatment.
  Ed. L. Gallo
  Plenum Publ. Corp. pp 443-451,1987.
  
  
• Fuster V, Chesebro JH, Badimon JJ, Badimon L
  Coronary Artery Disease, platelets and thrombosis.
  In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice
  Eds. Colman RW, Hirsch J, Marder VJ, Salzman EW.
  J. B. Lippincott Company, Phildelphia pp 1290-1300, 1987.
  
  
• Fuster V, Chesebro JH, Badimon L, Adams PC
  Antithrombotic therapy in cardiac disease: platelet inhibitors, anticoagulants, and fibrinolytics.
  In: Cardiology
  Ed. W. W. Parmley, K. Chatterjee.
  J.B. Lippincott Company, Philadelphia, Vol. I, (Chapter 25),pp 1-34, 1987.
  
  
• Fuster V, Chesebro JH, Adams PC, Badimon L
  Role of platelet inhibitor drugs in saphenous vein bypass graft disease.
  In: Antiplatelet therapy, twenty years' experience.
  Eds. Born G.V.R., Neri SeRneri G.G.
  Excerpta Medica. Amsterdam pp 244-259, 1987
  
  
• Fuster V, Badimon L, Badimon JJ, Adams P, Turitto VT, Chesebro JH
  Drugs interfering with platelet functions: Mechanisms and clinical relevance.
  In: Thrombosis and Haemostasis
  Eds. M. Verstraete, J. Vermylen, R. Lijnen, J. Arnout
  Leuven University Press, Leuven, Belgium (Chapter 15),pp 349-418, 1987
  
  
• Turitto VT, Weiss HJ, Baumgartner HR, Badimon L, Fuster V
  Fluid dynamics, the factor VIII/vWF complex, and thrombosis on vessel walls.
  In: Cerebral Ischemia and Hemorrheology
  Eds. A. Hartmann, W. Kuschinsky
  Springer Verlag, Berlin, pp 102-112, 1987.
  
• Badimon L, Badimon JJ and Fuster V
  High and very high density lipoproteins do not affect arachidonic acid incorporation into vessel wall phospholipids.
  Clinical Research 35:3,p507A, 1987
  
  
• Badimon JJ, Badimon L, Galvez A, Camuñas J, Fuster V
  Dynamics and localization of platelet deposition on a synthetic vascular graft: continuous imaging.
  Thrombosis and Haemostasia; 58,1, 1987
  
  
• Lam JYT, Chesebro JH, Badimon L, Badimon JJ, Bowie EJW, Fuster V
  Cod liver oil alters the platelet arterial wall response to injury by angioplasty.
  Circulation; 76:151,#0601, 1987
  

1988

• Fuster V, Badimon L, Badimon JJ, Chesebro JH
  Prevention of thromboembolism induced by prosthetic heart valves.
  Seminars in Thrombosis and Haemostasis 14, 50-58, 1988.
  
  
• Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J
  Insights into the pathogenesis of acute ischemic syndromes.
  Circulation 77, 1213-1220, 1988.
  
  
• Heras M, Chesebro JH, Penny WJ, Bailey KR, Lam JYT, Holmes DR, Reeder GS, Badimon L, Fuster V
  Importance of adequate heparin dosage in arterial angioplasty in a porcine model.
  Circulation 78, 654 -660, 1988.
  
  
• Badimon L, Badimon JJ, Turitto VT, Vallabhajosula S, Fuster V
  Platelet thrombus formation on collagen type I a model of deep vessel injury. Influence of blood rheology, von Willebrand Factor and blood coagulation
  Circulation 78, 1431-1442, 1988.
  
  
• Fuster V, Stein B, Badimon L, Chesebro JH
  Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction
  Journal of the American College of Cardiology 12, 78A-84A, 1988.
  
• Badimon L, Badimon JJ, Chesebro JH, Fuster V
  Inhibition of thrombus formation: blockage of adhesive glycoprotein mechanisms versus blockage of the ciclooxygenase pathway.
  Journal of the American College of Cardiology , 11,2:30A, 1988
  
  
• Penny WJ, Chesebro JH, Heras M, Badimon L, Fuster V
  In vivo identification of normal and damaged endothelium by quantitative coronary angiography and infusion of acetylcholine and bradykinin in pigs.
  Journal of the American College Cardiology , 11,2,29A, 1988
  
  
• Badimon L, Lassila R, Badimon JJ, Vallabhajosula S, Chesebro JH, Fuster V
  Residual thrombus is more thrombogenic than severely damaged vessel wall.
  Circulation ;78:119,#0474, 1988
  
  
• Alexopoulos D, Sanborn TA, Badimon JJ, Badimon L, Fuster V
  Coronary laser thermal angioplasty: Reduced platelet accumulation, thrombi and perforation with short laser pulses.
  Circulation ;78:450, 31795, 1988
  

1989

• Badimon L, Badimon JJ, Galvez A, Turitto VT, Fuster V
  Platelet interaction with vessel wall and collagen in pigs with homozygous von Willebrand's disease associated with abnormal collagen aggregation.
  Thrombosis and Haemostasis 61, 57-64, 1989.
  
  
• Badimon JJ, Badimon L, Galvez A, Dische R, Fuster V
  High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits
  Laboratory Investigation 60, 455-461, 1989.
  
  
• Heras M, Chesebro JH, Webster M, Mruk J, Grill D, Badimon L, Fuster V.
  Prevention of thrombosis by recombinant hirudin during arterial angioplasty in pigs : Comparison with heparin.
  Journal of the American College of Cardiology 13, 77A, 1989
  
  
• Badimon L, Badimon JJ, Turitto VT, Fuster V
  Role of von Willebrand Factor in mediating platelet-vessel wall interaction at low shear rate; the importance of perfusion conditions
  Blood 73, 961-967, 1989.
  
  
• Badimon L, Badimon JJ, Turitto VT, Rand J, Fuster V
  Functional behavior of vessels from pigs with von Willebrand disease. Values of platelet deposition are identical to those obtained on normal vessels.
  Arteriosclerosis 9, 184-188, 1989.
  
  
• Arad Y, Badimon JJ, Badimon L, Hembree WC, Ginsberg HN Dehydroepiandrosterone feeding
  prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit.
  Arteriosclerosis 9, 159-166, 1989.
  
  
• Heras M, Chesebro JH, Penny WJ, Bailey KR, Badimon L, Fuster V
  Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs: heparin versus recombinant hirudin, a specific thrombin inhibitor
  Circulation 79, 657-665, 1989.
  
  
• Badimon L, Badimon JJ
  Mechanisms of arterial thrombosis in non-parallel streamlines. Platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model.
  Journal of Clinical Investigation 84, 1134-1144, 1989.
  
  
• Stein B, Fuster V, Israel DH, Cohen M, Badimon L, Badimon JJ, Chesebro JH
  Platelet inhibitor agents in cardiovascular disease: An update.
  Journal of the American College of Cardiology 14, 813-836, 1989.
  
  
• Ip JH, Fuster V, Badimon L, Chesebro JH
  Interactions between blood and coronary arterial wall
  Current Opinion in Cardiology 4, 772-777, 1989.
  
• Fuster V, Israel DH, Badimon L, Chesebro JH
  Coronary artery disease: Role of antithrombotic therapy.
  In: Clinical Thrombosis
  Ed. Kwaan C, Samama M.
  CRC Press (Chapter 11), pp 151-179, 1989.
  
  
• Chesebro JH, Penny WJ, Heras M, Badimon L, Fuster V
  New possibilities for adjunctive therapy to prevent restenosis after arterial angioplasty.
  In: Interventional Cardiology : Future Directions.
  Eds. Vogel JHK, King SB.
  Ed. Mosby Company. (Chapter 30), pp 353-373, 1989.
  
  
• Badimon L, Badimon JJ, Lassila R, Turitto VT, Fuster V
  Thrombosis on stenosis: Mechanisms of thrombus growth and embolization on carotid atherosclerotic plaques.
  In: Cerebral Ischemia and Calcium.
  Eds. Hartmann A. and Kuschinsky W.
  Springer Verlag, Berlin, Heildelberg, (Chapter 40), pp 313-322, 1989.
  
  
• Turitto VT, Weiss HJ, Badimon L, Gemmell C, Nemerson Y
  Mediation of platelet and coagulation events by blood flow. Basic mechanisms of thrombosis in cerebral ischemia.
  In: Cerebral Ischemia and Calcium
  Eds. Hartmann A. and Kuschinsky W.
  Springer Verlag, Berlin, Heildelbeg, (Chapter 8), pp 60-68 , 1989.
  
  
• Stein B, Badimon L, Israel DH, Badimon JJ, Fuster V
  Thrombosis/platelets and other blood factors in acute coronary syndromes.
  In: Cardiovascular Clinics: Acute Myocardial Infarction.
  Eds. A. N. Brest and C. J. Pepine.
  F. A. Davis Company, Philadelphia pp 105-129, 1989.
  
  
• Turitto VT, Badimon L, Gemmel C
  Basic mechanisms of thrombosis on stenotic lesions: mediation of platelet and coagulation events by blood flow.
  In: Atherosclerosis. VIII.
  Eds. G. Crepaldi et al
  Elsevier Science Publishers, Exerpta Medica pp. 437-442, 1989.
  
  
• Chesebro JH, Penny WJ, Heras M, Badimon L, Fuster V
  Which antithrombotic therapy has proven most effective for the treatment of deep arterial injury, ruptured plaque and post-thrombolysis?
  In: Limitation of Infarct Size
  Eds. Schmutzle H, Rutsch W, Dougherty FC
  Springer-Verlag, Berlin Heildelberg , pp 223-233, 1989.
  
  
• Badimon L, Badimon JJ
  Aterosclerosis
  En : Hipertension en Geriatria
  Ed J.F Macias Núñez y M. Martinez Maldonado
  Ediciones CEA, S.A.,Madrid, (Capítulo 3) pp 35-45, 1989
  
  
• Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, Fuster V
  Thrombin inhibition by hirudin decreases platelet thrombus growth on areas of severe vessel wall injury.
  Journal of the Am erican College of Cardiology ,13:145A, 1989
  
  
• Heras M, Chesebro JH, Webster MB, Mruk J, Grill D, Badimon L, Fuster V
  Prevention of thrombosis by recombinant hirudin during arterial angioplasty in pigs: Comparison with heparin.
  Journal of the American College of Cardiology,13:#77A, 1989
  
  
• Badimon L, Badimon JJ, Cohen M, Chesebro J, Fuster V
  Thrombosis formation in stenotic and laminar flow conditions: effect of an antiplatelet GPIIb/IIIa
  Monoclonal Antibody Fragment [7E3 F ab')2]. Circulation ;80:422#1677, 1989
  
  
• Alexopoulos D, Sanborn TA, Marmur JD, Badimon JJ, Badimon L:
  Biological response to laser balloon angioplasty in the atherosclerotic rabbit.
  Circulation ;80:476#1892, 1989
  
  
• Webster MWI, Chesebro JH, Heras M, Mruk JS, Lam H, Wendland B, BadimonL, Fuster V
  New nonisotopic, in vivo technique of quantitating cellular proliferation in arterial media and intima.
  Circulation, 80:523#2080, 1989